PDB Short entry for 2BZH HEADER TRANSFERASE 18-AUG-05 2BZH TITLE CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH A RUTHENIUM TITLE 2 ORGANOMETALLIC LIGAND RU1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTO-ONCOGENE SERINE THREONINE PROTEIN KINASE PIM1; COMPND 3 CHAIN: B; COMPND 4 EC: 2.7.1.37; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES; COMPND 7 OTHER_DETAILS: ISOFORM MUTATION R250G SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: P11-TORONTO KEYWDS PIM1, KINASE, CANCER, LEUKEMIA, NUCLEAR PROTEIN, NUCLEOTIDE-BINDING, KEYWDS 2 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.E.DEBRECZENI,A.BULLOCK,S.KNAPP,F.VON DELFT,M.SUNDSTROM, AUTHOR 2 C.ARROWSMITH,J.WEIGELT,A.EDWARDS REVDAT 7 13-DEC-23 2BZH 1 REMARK REVDAT 6 08-MAY-19 2BZH 1 REMARK REVDAT 5 04-APR-18 2BZH 1 REMARK REVDAT 4 24-JAN-18 2BZH 1 AUTHOR JRNL REVDAT 3 13-JUL-11 2BZH 1 VERSN REVDAT 2 24-FEB-09 2BZH 1 VERSN REVDAT 1 08-DEC-05 2BZH 0 JRNL AUTH J.E.DEBRECZENI,A.BULLOCK,S.KNAPP,F.VON DELFT,M.SUNDSTROM, JRNL AUTH 2 C.ARROWSMITH,J.WEIGELT,A.EDWARDS JRNL TITL CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH JRNL TITL 2 RUTHENIUM ORGANOMETALLIC LIGANDS JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 32701 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.159 REMARK 3 R VALUE (WORKING SET) : 0.157 REMARK 3 FREE R VALUE : 0.190 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1751 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.95 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2363 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2400 REMARK 3 BIN FREE R VALUE SET COUNT : 140 REMARK 3 BIN FREE R VALUE : 0.3030 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2204 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 35 REMARK 3 SOLVENT ATOMS : 232 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 51.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.40000 REMARK 3 B22 (A**2) : 0.40000 REMARK 3 B33 (A**2) : -0.60000 REMARK 3 B12 (A**2) : 0.20000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.101 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.101 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.075 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.989 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.973 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.961 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2348 ; 0.012 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 2100 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3230 ; 1.279 ; 1.976 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4862 ; 0.827 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 284 ; 5.449 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 116 ;33.947 ;23.190 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 375 ;12.026 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 19 ;17.879 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 342 ; 0.087 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2619 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 518 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 446 ; 0.213 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 2103 ; 0.183 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1114 ; 0.182 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 1313 ; 0.079 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 156 ; 0.122 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 7 ; 0.043 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 46 ; 0.310 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 21 ; 0.176 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1419 ; 1.952 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2243 ; 2.933 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1192 ; 4.084 ; 8.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 957 ; 6.050 ;11.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 33 B 305 REMARK 3 ORIGIN FOR THE GROUP (A): -30.5614 -27.6615 -0.0702 REMARK 3 T TENSOR REMARK 3 T11: -0.2191 T22: -0.2413 REMARK 3 T33: -0.2176 T12: 0.0175 REMARK 3 T13: 0.0430 T23: -0.0291 REMARK 3 L TENSOR REMARK 3 L11: 1.9160 L22: 0.3146 REMARK 3 L33: 2.0299 L12: 0.4345 REMARK 3 L13: 1.2367 L23: 0.1042 REMARK 3 S TENSOR REMARK 3 S11: 0.0913 S12: 0.2026 S13: -0.0648 REMARK 3 S21: -0.2199 S22: 0.0950 S23: -0.1254 REMARK 3 S31: -0.0317 S32: 0.2000 S33: -0.1863 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 1307 B 1307 REMARK 3 ORIGIN FOR THE GROUP (A): -22.6759 -34.6987 -2.7785 REMARK 3 T TENSOR REMARK 3 T11: -0.0943 T22: 0.1930 REMARK 3 T33: 0.0202 T12: 0.1202 REMARK 3 T13: 0.0180 T23: 0.0482 REMARK 3 L TENSOR REMARK 3 L11: 5.6909 L22: 35.1530 REMARK 3 L33: 8.2297 L12: 5.3701 REMARK 3 L13: -6.6864 L23: -9.6623 REMARK 3 S TENSOR REMARK 3 S11: -0.1811 S12: 0.6169 S13: -0.9678 REMARK 3 S21: -0.8865 S22: 0.3881 S23: 0.5056 REMARK 3 S31: 0.6939 S32: -0.1040 S33: -0.2069 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2BZH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 18-AUG-05. REMARK 100 THE DEPOSITION ID IS D_1290025357. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-MAR-05 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU IMAGE PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 34487 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 5.550 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 14.4200 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.69 REMARK 200 R MERGE FOR SHELL (I) : 0.33000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.250 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1XWS REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 67.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.70 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M SUCCINATE PHOSPHATE GLYCINE REMARK 280 BUFFER PH 6, 30% PEG1K, 0.5% DMSO, SITTING DROP, VAPOR DIFFUSION, REMARK 280 SITTING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 65 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/6 REMARK 290 6555 X-Y,X,Z+5/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 53.81733 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 26.90867 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 40.36300 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 13.45433 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 67.27167 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 POSSIBLE ROLE IN SIGNAL TRANSDUCTION IN BLOOD CELLS REMARK 400 ENGINEERED RESIDUE IN CHAIN B, ARG 250 TO GLY REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET B 1 REMARK 465 LEU B 2 REMARK 465 LEU B 3 REMARK 465 SER B 4 REMARK 465 LYS B 5 REMARK 465 ILE B 6 REMARK 465 ASN B 7 REMARK 465 SER B 8 REMARK 465 LEU B 9 REMARK 465 ALA B 10 REMARK 465 HIS B 11 REMARK 465 LEU B 12 REMARK 465 ARG B 13 REMARK 465 ALA B 14 REMARK 465 ALA B 15 REMARK 465 PRO B 16 REMARK 465 CYS B 17 REMARK 465 ASN B 18 REMARK 465 ASP B 19 REMARK 465 LEU B 20 REMARK 465 HIS B 21 REMARK 465 ALA B 22 REMARK 465 THR B 23 REMARK 465 LYS B 24 REMARK 465 LEU B 25 REMARK 465 ALA B 26 REMARK 465 PRO B 27 REMARK 465 GLY B 28 REMARK 465 LYS B 29 REMARK 465 GLU B 30 REMARK 465 LYS B 31 REMARK 465 LEU B 307 REMARK 465 SER B 308 REMARK 465 PRO B 309 REMARK 465 GLY B 310 REMARK 465 PRO B 311 REMARK 465 SER B 312 REMARK 465 LYS B 313 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU B 32 CG CD OE1 OE2 REMARK 470 LEU B 34 CG CD1 CD2 REMARK 470 ASP B 76 OD1 OD2 REMARK 470 LEU B 80 CG CD1 CD2 REMARK 470 ASN B 82 CG OD1 ND2 REMARK 470 GLU B 243 CD OE1 OE2 REMARK 470 ARG B 256 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 262 CD OE1 OE2 REMARK 470 SER B 306 OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 ND2 ASN B 160 O HOH B 2110 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG B 145 NE - CZ - NH2 ANGL. DEV. = 3.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN B 82 5.02 -67.01 REMARK 500 ASP B 167 44.35 -146.34 REMARK 500 ASP B 186 81.60 62.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B1309 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HB1 B1307 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B1308 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1XQZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HPIM-1 KINASE AT 2.1 A RESOLUTION REMARK 900 RELATED ID: 1XR1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HPIM-1 KINASE IN COMPLEX WITH AMP-PNPAT 2.1 A REMARK 900 RESOLUTION REMARK 900 RELATED ID: 1XWS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN PIM1 KINASE DOMAIN REMARK 900 RELATED ID: 1YHS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PIM-1 BOUND TO STAUROSPORINE REMARK 900 RELATED ID: 1YI3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PIM-1 BOUND TO LY294002 REMARK 900 RELATED ID: 1YI4 RELATED DB: PDB REMARK 900 STRUCTURE OF PIM-1 BOUND TO ADENOSINE REMARK 900 RELATED ID: 1YWV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF PROTO-ONCOGENE KINASE PIM1: A TARGETOF REMARK 900 ABERRANT SOMATIC HYPERMUTATIONS IN DIFFUSE LARGE CELLLYMPHOMA REMARK 900 RELATED ID: 1YXS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF KINASE PIM1 WITH P123M MUTATION REMARK 900 RELATED ID: 1YXT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH AMPPNP REMARK 900 RELATED ID: 1YXU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH AMP REMARK 900 RELATED ID: 1YXV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH 3,4-DIHYDROXY-1- REMARK 900 METHYLQUINOLIN-2(1H)-ONE REMARK 900 RELATED ID: 1YXX RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH (3E)-3-[(4- REMARK 900 HYDROXYPHENYL)IMINO]-1H- INDOL-2(3H)-ONE REMARK 900 RELATED ID: 2BIK RELATED DB: PDB REMARK 900 HUMAN PIM1 PHOSPHORYLATED ON SER261 REMARK 900 RELATED ID: 2BIL RELATED DB: PDB REMARK 900 THE HUMAN PROTEIN KINASE PIM1 IN COMPLEX WITH ITS CONSENSUS PEPTIDE REMARK 900 PIMTIDE REMARK 900 RELATED ID: 2BZI RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH A RUTHENIUM REMARK 900 ORGANOMETALLIC LIGAND RU2 REMARK 900 RELATED ID: 2BZJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH A RUTHENIUM REMARK 900 ORGANOMETALLIC LIGAND RU3 REMARK 900 RELATED ID: 2BZK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH AMPPNP AND REMARK 900 PIMTIDE REMARK 999 REMARK 999 SEQUENCE REMARK 999 ISOFORM MUTATION R250G DBREF 2BZH B 1 313 UNP P11309 PIM1_HUMAN 1 313 SEQADV 2BZH GLY B 250 UNP P11309 ARG 250 ENGINEERED MUTATION SEQRES 1 B 313 MET LEU LEU SER LYS ILE ASN SER LEU ALA HIS LEU ARG SEQRES 2 B 313 ALA ALA PRO CYS ASN ASP LEU HIS ALA THR LYS LEU ALA SEQRES 3 B 313 PRO GLY LYS GLU LYS GLU PRO LEU GLU SER GLN TYR GLN SEQRES 4 B 313 VAL GLY PRO LEU LEU GLY SER GLY GLY PHE GLY SER VAL SEQRES 5 B 313 TYR SER GLY ILE ARG VAL SER ASP ASN LEU PRO VAL ALA SEQRES 6 B 313 ILE LYS HIS VAL GLU LYS ASP ARG ILE SER ASP TRP GLY SEQRES 7 B 313 GLU LEU PRO ASN GLY THR ARG VAL PRO MET GLU VAL VAL SEQRES 8 B 313 LEU LEU LYS LYS VAL SER SER GLY PHE SER GLY VAL ILE SEQRES 9 B 313 ARG LEU LEU ASP TRP PHE GLU ARG PRO ASP SER PHE VAL SEQRES 10 B 313 LEU ILE LEU GLU ARG PRO GLU PRO VAL GLN ASP LEU PHE SEQRES 11 B 313 ASP PHE ILE THR GLU ARG GLY ALA LEU GLN GLU GLU LEU SEQRES 12 B 313 ALA ARG SER PHE PHE TRP GLN VAL LEU GLU ALA VAL ARG SEQRES 13 B 313 HIS CYS HIS ASN CYS GLY VAL LEU HIS ARG ASP ILE LYS SEQRES 14 B 313 ASP GLU ASN ILE LEU ILE ASP LEU ASN ARG GLY GLU LEU SEQRES 15 B 313 LYS LEU ILE ASP PHE GLY SER GLY ALA LEU LEU LYS ASP SEQRES 16 B 313 THR VAL TYR THR ASP PHE ASP GLY THR ARG VAL TYR SER SEQRES 17 B 313 PRO PRO GLU TRP ILE ARG TYR HIS ARG TYR HIS GLY ARG SEQRES 18 B 313 SER ALA ALA VAL TRP SER LEU GLY ILE LEU LEU TYR ASP SEQRES 19 B 313 MET VAL CYS GLY ASP ILE PRO PHE GLU HIS ASP GLU GLU SEQRES 20 B 313 ILE ILE GLY GLY GLN VAL PHE PHE ARG GLN ARG VAL SER SEQRES 21 B 313 SER GLU CYS GLN HIS LEU ILE ARG TRP CYS LEU ALA LEU SEQRES 22 B 313 ARG PRO SER ASP ARG PRO THR PHE GLU GLU ILE GLN ASN SEQRES 23 B 313 HIS PRO TRP MET GLN ASP VAL LEU LEU PRO GLN GLU THR SEQRES 24 B 313 ALA GLU ILE HIS LEU HIS SER LEU SER PRO GLY PRO SER SEQRES 25 B 313 LYS HET HB1 B1307 30 HET EDO B1308 4 HET CL B1309 1 HETNAM HB1 RUTHENIUM-PYRIDOCARBAZOLE-1 HETNAM EDO 1,2-ETHANEDIOL HETNAM CL CHLORIDE ION HETSYN EDO ETHYLENE GLYCOL FORMUL 2 HB1 C23 H13 N3 O3 RU FORMUL 3 EDO C2 H6 O2 FORMUL 4 CL CL 1- FORMUL 5 HOH *232(H2 O) HELIX 1 1 PRO B 33 GLN B 37 1 5 HELIX 2 2 MET B 88 SER B 97 1 10 HELIX 3 3 LEU B 129 GLY B 137 1 9 HELIX 4 4 GLN B 140 CYS B 161 1 22 HELIX 5 5 LYS B 169 GLU B 171 5 3 HELIX 6 6 THR B 204 SER B 208 5 5 HELIX 7 7 PRO B 209 HIS B 216 1 8 HELIX 8 8 HIS B 219 GLY B 238 1 20 HELIX 9 9 HIS B 244 GLY B 251 1 8 HELIX 10 10 SER B 260 LEU B 271 1 12 HELIX 11 11 ARG B 274 ARG B 278 5 5 HELIX 12 12 THR B 280 ASN B 286 1 7 HELIX 13 13 HIS B 287 GLN B 291 5 5 HELIX 14 14 LEU B 295 LEU B 304 1 10 SHEET 1 BA 5 TYR B 38 GLY B 47 0 SHEET 2 BA 5 GLY B 50 ARG B 57 -1 O GLY B 50 N GLY B 47 SHEET 3 BA 5 PRO B 63 GLU B 70 -1 O VAL B 64 N GLY B 55 SHEET 4 BA 5 SER B 115 GLU B 121 -1 O PHE B 116 N VAL B 69 SHEET 5 BA 5 LEU B 106 GLU B 111 -1 N LEU B 107 O ILE B 119 SHEET 1 BB 2 TRP B 77 GLU B 79 0 SHEET 2 BB 2 ARG B 85 PRO B 87 -1 O VAL B 86 N GLY B 78 SHEET 1 BC 3 VAL B 126 ASP B 128 0 SHEET 2 BC 3 ILE B 173 ASP B 176 -1 O ILE B 175 N GLN B 127 SHEET 3 BC 3 GLU B 181 LEU B 184 -1 O GLU B 181 N ASP B 176 SHEET 1 BD 2 VAL B 163 LEU B 164 0 SHEET 2 BD 2 ALA B 191 LEU B 192 -1 O ALA B 191 N LEU B 164 CISPEP 1 GLU B 124 PRO B 125 0 -5.88 SITE 1 AC1 2 GLU B 70 ARG B 73 SITE 1 AC2 14 GLY B 45 PHE B 49 VAL B 52 ALA B 65 SITE 2 AC2 14 ILE B 104 LEU B 120 GLU B 121 ARG B 122 SITE 3 AC2 14 VAL B 126 ASP B 128 GLU B 171 LEU B 174 SITE 4 AC2 14 ILE B 185 HOH B2231 SITE 1 AC3 6 ARG B 156 ASN B 160 SER B 261 HOH B2187 SITE 2 AC3 6 HOH B2190 HOH B2232 CRYST1 97.529 97.529 80.726 90.00 90.00 120.00 P 65 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010253 0.005920 0.000000 0.00000 SCALE2 0.000000 0.011840 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012388 0.00000